Description

Composition

• GHK-Cu: 50 mg
• KPV: 10 mg
• BPC-157: 10 mg
• TB-500 (Thymosin Beta 4): 10 mg
• Appearance: lyophilized powder in a sealed research vial

Research Focus (non-clinical)

• Combined evaluation of copper peptide, KPV tripeptide, BPC-157, and TB-500 in in-vitro or ex-vivo assay systems
• Assay development, including chromatographic separation of four co-formulated peptides
• Stability characterization of a four-analyte lyophilized blend under laboratory storage conditions
• Method documentation for HPLC/LC-MS identity and purity assessments

Documentation

• Lot-specific COA available
• Batch and lot traceability

Important Notice

• For research use only
• Not for human consumption
• Not intended to diagnose, treat, cure, or prevent any disease

Quality & Manufacturing

• Lot-specific COA
• Lyophilized for transit stability; batch traceable
• Tamper-evident seal; lot & test date on each vial
• No MOQ for online orders
• Bulk orders for physical locations start at 25-unit minimum

”
,”

A single-component research material supplied for controlled research environments. Suitable for studies involving peptide characterization and method development in model systems.

Composition

• KPV: 5 mg
• Appearance: lyophilized powder in a sealed research vial

Research Focus (non-clinical)

• Peptide identity and purity assessment via HPLC/LC-MS
• Assay development and calibration for quantitative analysis
• Chromatographic method optimization for impurity profiling and peak resolution
• Stability characterization of a lyophilized peptide under laboratory storage conditions

Documentation

• COA pending — third-party verification in progress

Important Notice

• For research use only
• Not for human consumption
• Not intended to diagnose, treat, cure, or prevent any disease

Quality & Manufacturing

• Manufactured in the USA in an ISO 9001–based, cGMP-aligned facility 
• COA pending — third-party verification in progress
• Lyophilized for transit stability; batch traceable
• Tamper-evident seal; lot & test date on each vial
• No MOQ for online orders
• Bulk orders for physical locations start at 25-unit minimum

”
,”

A single-component research material supplied for controlled research environments. Suitable for studies involving peptide characterization and method development in model systems.

Composition

• LL-37: 5 mg
• Appearance: lyophilized powder in a sealed research vial

Research Focus (non-clinical)

• Peptide identity and purity assessment via HPLC/LC-MS
• Assay development and calibration for quantitative analysis
• Chromatographic method optimization for impurity profiling and peak resolution
• Stability characterization of a lyophilized peptide under laboratory storage conditions

Documentation

• COA pending — third-party verification in progress

Important Notice

• For research use only
• Not for human consumption
• Not intended to diagnose, treat, cure, or prevent any disease

Quality & Manufacturing

• Manufactured in the USA in an ISO 9001–based, cGMP-aligned facility 
• COA pending — third-party verification in progress
• Lyophilized for transit stability; batch traceable
• Tamper-evident seal; lot & test date on each vial
• No MOQ for online orders
• Bulk orders for physical locations start at 25-unit minimum

”
,”

A single-component research material supplied for controlled research environments. Suitable for studies involving peptide characterization and method development in model systems.

Composition

• LL-37: 5 mg
• Appearance: lyophilized powder in a sealed research vial

Research Focus (non-clinical)

• Peptide identity and purity assessment via HPLC/LC-MS
• Assay development and calibration for quantitative analysis
• Chromatographic method optimization for impurity profiling and peak resolution
• Stability characterization of a lyophilized peptide under laboratory storage conditions

Documentation

• COA pending — third-party verification in progress

Important Notice

• For research use only
• Not for human consumption
• Not intended to diagnose, treat, cure, or prevent any disease

Quality & Manufacturing

• Manufactured in the USA in an ISO 9001–based, cGMP-aligned facility 
• COA pending — third-party verification in progress
• Lyophilized for transit stability; batch traceable
• Tamper-evident seal; lot & test date on each vial
• No MOQ for online orders
• Bulk orders for physical locations start at 25-unit minimum